Pamela Esposito - Aug 4, 2021 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role
Chief Business Officer
Signature
/s/ Jean Franchi, attorney-in-fact
Stock symbol
REPL
Transactions as of
Aug 4, 2021
Transactions value $
-$587,322
Form type
4
Date filed
8/6/2021, 09:01 PM
Previous filing
Jul 22, 2021
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REPL Common Stock Options Exercise $65.1K +4.2K +2% $15.50 214K Aug 4, 2021 Direct
transaction REPL Common Stock Sale -$147K -4.2K -1.96% $35.00 210K Aug 4, 2021 Direct F1, F2
transaction REPL Common Stock Options Exercise $400K +25.8K +12.28% $15.50 236K Aug 5, 2021 Direct
transaction REPL Common Stock Sale -$905K -25.8K -10.93% $35.09 210K Aug 5, 2021 Direct F1, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REPL Employee Stock Option (right to buy) Options Exercise $0 -4.2K -5.54% $0.00 71.6K Aug 4, 2021 Common Stock 4.2K $15.50 Direct F5
transaction REPL Employee Stock Option (right to buy) Options Exercise $0 -25.8K -36.06% $0.00 45.8K Aug 5, 2021 Common Stock 25.8K $15.50 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2 The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.05. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.38. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 458,102 shares of the Issuer's common stock, 300,811 of which are exercisable as of the date hereof.
F5 25% of the shares underlying this stock option vested on April 1, 2020, and the remainder of the shares underlying this stock option vested or will vest, as applicable, in 36 approximately equal monthly installments thereafter.